Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Minimum Concentration of Tranexamic Acid Required to Inhibit Fibrinolysis in a Population of Pregnant Women at Term.

NCT02579941 is registered in ClinicalTrials.gov with Brugmann University Hospital as lead sponsor.

NCT NCT02579941
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02579941 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Minimum Concentration of Tranexamic Acid Required to Inhibit Fibrinolysis in a Population of Pregnant Women at Term.
Lead sponsor
Brugmann University Hospital
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2015
Completion date
April 30, 2016
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperfibrinolysis